Growth Metrics

Tenon Medical (TNON) EBIAT (2021 - 2025)

Tenon Medical has reported EBIAT over the past 5 years, most recently at -$2.8 million for Q4 2025.

  • Quarterly results put EBIAT at -$2.8 million for Q4 2025, up 8.26% from a year ago — trailing twelve months through Dec 2025 was -$12.6 million (up 8.17% YoY), and the annual figure for FY2025 was -$12.6 million, up 8.17%.
  • EBIAT for Q4 2025 was -$2.8 million at Tenon Medical, up from -$3.3 million in the prior quarter.
  • Over the last five years, EBIAT for TNON hit a ceiling of -$201000.0 in Q1 2021 and a floor of -$7.9 million in Q4 2022.
  • Median EBIAT over the past 5 years was -$3.2 million (2022), compared with a mean of -$3.4 million.
  • Biggest five-year swings in EBIAT: plummeted 1070.65% in 2022 and later soared 60.35% in 2023.
  • Tenon Medical's EBIAT stood at -$2.8 million in 2021, then plummeted by 178.15% to -$7.9 million in 2022, then soared by 60.35% to -$3.1 million in 2023, then rose by 1.5% to -$3.1 million in 2024, then increased by 8.26% to -$2.8 million in 2025.
  • The last three reported values for EBIAT were -$2.8 million (Q4 2025), -$3.3 million (Q3 2025), and -$2.8 million (Q2 2025) per Business Quant data.